Cargando…
Implications of government subsidy on the vaccine product R&D when the buyer is risk averse
This paper analyses the choice of subsidy offered to a vaccine supply chain with a risk-averse buyer. We find that for a higher innovation effort and level of social benefits, the per-unit production subsidy is better when there is a low innovation cost coefficient, a low level of risk aversion, or...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854192/ https://www.ncbi.nlm.nih.gov/pubmed/33551663 http://dx.doi.org/10.1016/j.tre.2020.102220 |